Laboratory Corporation of America Holdings – LSE:0JSY.L

Laboratory Corporation of America Holdings stock price today

$177.68
-52.26
-22.73%
Financial Health
0
1
2
3
4
5
6
7
8
9

Laboratory Corporation of America Holdings stock price monthly change

+10.94%
month

Laboratory Corporation of America Holdings stock price quarterly change

+10.94%
quarter

Laboratory Corporation of America Holdings stock price yearly change

+2.47%
year

Laboratory Corporation of America Holdings key metrics

Market Cap
18.99B
Enterprise value
25.47B
P/E
44.44
EV/Sales
2.00
EV/EBITDA
18.00
Price/Sales
1.51
Price/Book
2.36
PEG ratio
18.81
EPS
4.99
Revenue
12.30B
EBITDA
1.70B
Income
433.1M
Revenue Q/Q
-15.91%
Revenue Y/Y
-16.63%
Profit margin
3.43%
Oper. margin
8.8%
Gross margin
26.49%
EBIT margin
8.8%
EBITDA margin
13.88%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Laboratory Corporation of America Holdings stock price history

Laboratory Corporation of America Holdings stock forecast

Laboratory Corporation of America Holdings financial statements

Laboratory Corporation of America Holdings (LSE:0JSY.L): Profit margin
Jun 2023 3.03B 188.9M 6.23%
Sep 2023 3.05B 183.3M 6%
Dec 2023 3.03B -167.1M -5.51%
Mar 2024 3.17B 228M 7.18%
Laboratory Corporation of America Holdings (LSE:0JSY.L): Analyst Estimates
Sep 2025 3.37B 350.66M 10.4%
Oct 2025 3.42B 344.61M 10.07%
Dec 2025 3.39B 333.47M 9.82%
Mar 2026 3.40B 365.27M 10.73%
  • Analysts Price target

  • Financials & Ratios estimates

1.56%
Yield TTM
Laboratory Corporation of America Holdings (LSE:0JSY.L): Payout ratio
Payout ratio 56.05%
Laboratory Corporation of America Holdings (LSE:0JSY.L): Dividend Yield
2019
2020
2021
2022 1.06%
2023 1.28%
Laboratory Corporation of America Holdings (LSE:0JSY.L): Debt to assets
Jun 2023 17705700000 8.91B 50.34%
Sep 2023 16886000000 8.99B 53.26%
Dec 2023 16725099999 8.83B 52.82%
Mar 2024 16531000000 8.55B 51.76%
Laboratory Corporation of America Holdings (LSE:0JSY.L): Cash Flow
Jun 2023 351.4M -253.6M 1.54B
Sep 2023 275.5M -487.6M -987.8M
Dec 2023 579.6M -330.6M -446.5M
Mar 2024 -29.8M -393.1M -11.7M

Laboratory Corporation of America Holdings alternative data

Laboratory Corporation of America Holdings (LSE:0JSY.L): Employee count
Aug 2023 70,400
Sep 2023 60,000
Oct 2023 60,000
Nov 2023 60,000
Dec 2023 60,000
Jan 2024 60,000
Feb 2024 60,000
Mar 2024 56,950
Apr 2024 56,950
May 2024 67,000
Jun 2024 67,000
Jul 2024 67,000

Laboratory Corporation of America Holdings other data

Insider Compensation
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH (1974) Executive Vice President, Pres of Diagnostics & Chief Medical Officer
$3,360,000
Mr. Mark S. Schroeder (1961) Executive Vice President and Pres of Diagnostics Laboratory Operations & Global Supply Chain
$3,190,000
Mr. Adam H. Schechter (1965) Pres, Chief Executive Officer & Chairman $1,790,000
Mr. Glenn A. Eisenberg (1961) Chief Financial Officer & Executive Vice President $1,460,000
Mr. Lance V. Berberian (1963) Executive Vice President and Chief Information & Technology Officer
$876,620
Dr. Michelle Abelson Laboratory Director of Operations
Mr. Peter J. Wilkinson Senior Vice President & Chief Accounting Officer
Dr. Marcia T. Eisenberg Chief Scientific Officer & Senior Vice President
Ms. Sandra D. Van Der Vaart Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Corporation Sec.
Clarissa Willett Vice President of Investor Relations
  • What's the price of Laboratory Corporation of America Holdings stock today?

    One share of Laboratory Corporation of America Holdings stock can currently be purchased for approximately $177.68.

  • When is Laboratory Corporation of America Holdings's next earnings date?

    Unfortunately, Laboratory Corporation of America Holdings's (0JSY.L) next earnings date is currently unknown.

  • Does Laboratory Corporation of America Holdings pay dividends?

    Yes, Laboratory Corporation of America Holdings pays dividends and its trailing 12-month yield is 1.56% with 56% payout ratio. The last Laboratory Corporation of America Holdings stock dividend of undefined was paid on 10 Sep 2025.

  • How much money does Laboratory Corporation of America Holdings make?

    Laboratory Corporation of America Holdings has a market capitalization of 18.99B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 18.25% to 12.16B US dollars.

  • What is Laboratory Corporation of America Holdings's stock symbol?

    Laboratory Corporation of America Holdings is traded on the LSE under the ticker symbol "0JSY.L".

  • What is Laboratory Corporation of America Holdings's primary industry?

    Company operates in the Healthcare sector and Medical - Equipment & Services industry.

  • How do i buy shares of Laboratory Corporation of America Holdings?

    Shares of Laboratory Corporation of America Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Laboratory Corporation of America Holdings's key executives?

    Laboratory Corporation of America Holdings's management team includes the following people:

    • Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH Executive Vice President, Pres of Diagnostics & Chief Medical Officer(age: 51, pay: $3,360,000)
    • Mr. Mark S. Schroeder Executive Vice President and Pres of Diagnostics Laboratory Operations & Global Supply Chain(age: 64, pay: $3,190,000)
    • Mr. Adam H. Schechter Pres, Chief Executive Officer & Chairman(age: 60, pay: $1,790,000)
    • Mr. Glenn A. Eisenberg Chief Financial Officer & Executive Vice President(age: 64, pay: $1,460,000)
    • Mr. Lance V. Berberian Executive Vice President and Chief Information & Technology Officer(age: 62, pay: $876,620)
    • Dr. Michelle Abelson Laboratory Director of Operations
    • Mr. Peter J. Wilkinson Senior Vice President & Chief Accounting Officer
    • Dr. Marcia T. Eisenberg Chief Scientific Officer & Senior Vice President
    • Ms. Sandra D. Van Der Vaart Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Corporation Sec.
    • Clarissa Willett Vice President of Investor Relations
  • How many employees does Laboratory Corporation of America Holdings have?

    As Jul 2024, Laboratory Corporation of America Holdings employs 67,000 workers, which is 18% more then previous quarter.

  • When Laboratory Corporation of America Holdings went public?

    Laboratory Corporation of America Holdings is publicly traded company for more then 7 years since IPO on 29 Jan 2018.

  • What is Laboratory Corporation of America Holdings's official website?

    The official website for Laboratory Corporation of America Holdings is labcorp.com.

  • Where are Laboratory Corporation of America Holdings's headquarters?

    Laboratory Corporation of America Holdings is headquartered at 358 South Main Street, Burlington, NC.

  • How can i contact Laboratory Corporation of America Holdings?

    Laboratory Corporation of America Holdings's mailing address is 358 South Main Street, Burlington, NC and company can be reached via phone at +33 62291127.

Laboratory Corporation of America Holdings company profile:

Laboratory Corporation of America Holdings

labcorp.com
Exchange:

LSE

Full time employees:

67,000

Industry:

Medical - Equipment & Services

Sector:

Healthcare

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

358 South Main Street
Burlington, NC 27215

:
ISIN: US50540R4092
: